Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
28.16
-2.59 (-8.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corporation - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Why Does Cathie Wood Like This Healthcare Stock So Much?
May 06, 2021
Twist Bioscience brings to mind another genomic revolution pioneer.
Via
The Motley Fool
Earnings Scheduled For May 6, 2021
May 06, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
3 Exciting Biotech Stocks to Buy Right Now
April 30, 2021
Gene therapies could be poised to enter an era of extraordinarily rapid advancement.
Via
The Motley Fool
Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications
April 28, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2021 Second Quarter Financial Results on Thursday, May 6, 2021
April 22, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Expand Oregon Lease, Supporting Future Growth
April 16, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities
April 14, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2021
April 12, 2021
Upgrades For Eni SpA (NYSE:E), Credit Suisse upgraded the previous rating of Underperform to Neutral. For the fourth quarter, Eni had an EPS of $0.02, compared to year-ago...
Via
Benzinga
Twist Bioscience Exercises Option to Purchase Custom Designed Antibody Library and Optimization Software
April 12, 2021
From
Twist Bioscience
Via
Business Wire
Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report
April 09, 2021
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg...
Via
Benzinga
AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests
April 07, 2021
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories
April 07, 2021
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.